import StrategicServicePage from '@/pages/templates/StrategicServicePage';

export default function DiabetesMarketResearchUae() {
  return (
    <StrategicServicePage
      title="Diabetes Market Research UAE | BioNixus"
      description="Diabetes market research in UAE for pharmaceutical teams covering treatment pathway mapping, HCP prescribing behavior, payer access barriers, and patient adherence insight."
      canonicalUrl="https://www.bionixus.com/diabetes-market-research-uae"
      breadcrumbLabel="Diabetes Market Research UAE"
      h1="Diabetes Market Research UAE"
      intro="BioNixus delivers diabetes market research in UAE covering HCP prescribing pathways, payer access barriers, treatment switching dynamics, and patient adherence drivers for pharmaceutical and device teams."
      links={[
        { to: '/uae-pharmaceutical-market-research', label: 'UAE pharmaceutical market research', primary: true },
        { to: '/patient-journey-research-gcc', label: 'Patient journey research GCC', primary: true },
        { to: '/uae-market-access-research', label: 'UAE market access research' },
        { to: '/contact', label: 'Request diabetes market research scope' },
      ]}
      bullets={[
        'HCP prescribing pathway mapping across endocrinologists, diabetologists, and primary care in UAE.',
        'Payer access barrier analysis covering DHA, DOH, and MOHAP formulary requirements for diabetes therapies.',
        'Patient adherence driver research measuring persistence, drop-off, and behavioral barriers in UAE diabetes cohorts.',
      ]}
      decisionPoints={[
        {
          title: 'Why it matters',
          body: 'UAE diabetes prevalence among the highest globally creates a large addressable market where prescribing pathway clarity and payer access barriers directly determine brand performance.',
        },
        {
          title: 'What the evidence says',
          body: 'Treatment switching dynamics in UAE diabetes reveal decision triggers at the HCP and payer level that shape launch sequencing, access strategy, and lifecycle management.',
        },
        {
          title: 'What to do next',
          body: 'Define your diabetes category focus — therapy area, HCP segment, or payer landscape — and commission a launch-ready or lifecycle market research study.',
        },
      ]}
      metrics={[
        {
          label: 'Disease burden',
          value: '~19% adult prevalence (UAE IDF)',
          detail: 'UAE carries one of the highest diabetes prevalence rates globally, creating a priority market for pharmaceutical teams.',
        },
        {
          label: 'Payer landscape',
          value: 'DHA/DOH/MOHAP mapped',
          detail: 'Full UAE health authority payer landscape coverage for diabetes formulary access and reimbursement research.',
        },
        {
          label: 'Output',
          value: 'Launch and lifecycle ready',
          detail: 'Research designed to support both pre-launch positioning and post-launch lifecycle decisions in UAE diabetes.',
        },
      ]}
    />
  );
}
